Arvelle Therapeutics funding Arvelle Therapeutics funding profile: 12M total raised. Latest round: Series B. Backed by Forbion, Jeito Capital, UPMC Enterprises. Headquarters: Basel, Switzerland InvestorsForbionJeito CapitalUPMC EnterprisesSofinnova PartnersPolaris Partners Fundraising guidesCross-Border M&A: A Founder's Playbook for International AcquisitionsFinancial Synergies In M&A: A Founder's Tactical GuideHe Built A Billion Company To Innovate Fast-Charging Batteries For EVs And Is Now Exploring Lithium Extraction More company funding profilesArvinasARX RoboticsArva Browse the company funding database · Browse investors · Fundraising library All companies by funding raisedCompanies page 2San Francisco startupsNew York startupsLondon startupsBoston startupsAustin startupsSeed stage companiesSeries A stage companiesSeries B stage companiesSeries C stage companiesGrowth stage companiesIpo stage companiesStartups funded in 2026
